{
    "title": "COVID-19 treatment, Keytruda boost drugmaker Merck in Q1",
    "url": "https://www.dailymail.co.uk/wires/ap/article-10763011/COVID-19-treatment-Keytruda-boost-Merck-1Q.html",
    "date": "2022-04-28",
    "keywords": [
        "merck",
        "treatment",
        "lagevrio",
        "share",
        "covid19",
        "quarter",
        "year",
        "file",
        "thursday",
        "analyst",
        "company",
        "paxlovid",
        "co",
        "blockbuster",
        "cancer",
        "drug",
        "drugmaker",
        "forecast",
        "molnupiravir",
        "pfizer",
        "photo",
        "ap",
        "virus",
        "revenue",
        "keytruda",
        "profit",
        "firstquarter",
        "coronavirus",
        "brand",
        "name",
        "call",
        "data",
        "recourse",
        "government",
        "officer",
        "caroline",
        "litchfield",
        "time",
        "medication",
        "home",
        "convenience",
        "catch",
        "access",
        "use",
        "ridgeback",
        "research",
        "omicron",
        "surge",
        "breakthrough",
        "fight",
        "pandemic",
        "risk",
        "hospital",
        "president",
        "joe",
        "biden",
        "availability",
        "inc",
        "jersey",
        "morning",
        "dow",
        "average",
        "component",
        "tom",
        "murphy",
        "twitter",
        "httpstwittercomthpmurphy",
        "headquarters",
        "kenilworth",
        "photoseth",
        "wenig"
    ],
    "category": [
        "wires",
        "ap"
    ]
}